Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevanac as Adjunct to Laser for Diabetic Macular Edema
NCT02443012Phase 4Completed
- Sponsor
- Universiti Sains Malaysia
- Start
- Mar 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nepafenac in diabetic macular edema (DME), sponsored by Universiti Sains Malaysia. Started Mar 2013; status: completed.
02
Drugs
nepafenac
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02443012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02443012.